Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer-Reference-Cited by-同舟云学术

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer

Published:2014-08 Issue:8 Volume:15 Page:
ISSN:1474-760X
Container-title:Genome Biology
language:en
Short-container-title:Genome Biol

Author:

Wyatt Alexander W,Mo Fan,Wang Kendric,McConeghy Brian,Brahmbhatt Sonal,Jong Lina,Mitchell Devon M,Johnston Rebecca L,Haegert Anne,Li Estelle,Liew Janet,Yeung Jake,Shrestha Raunak,Lapuk Anna V,McPherson Andrew,Shukin Robert,Bell Robert H,Anderson Shawn,Bishop Jennifer,Hurtado-Coll Antonio,Xiao Hong,Chinnaiyan Arul M,Mehra Rohit,Lin Dong,Wang Yuzhuo,Fazli Ladan,Gleave Martin E,Volik Stanislav V,Collins Colin C

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13059-014-0426-y.pdf

Reference61 articles.

1. Wyatt AW, Mo F, Wang Y, Collins CC: The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing. Asian J Androl. 2013, 15: 301-308. 10.1038/aja.2013.13.

2. Spans L, Clinckemalie L, Helsen C, Vanderschueren D, Boonen S, Lerut E, Joniau S, Claessens F: The genomic landscape of prostate cancer. Int J Mol Sci. 2013, 14: 10822-10851. 10.3390/ijms140610822.

3. Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, Menon A, Jing X, Cao Q, Han B, Yu J, Wang L, Montie JE, Rubin MA, Pienta KJ, Roulston D, Shah RB, Varambally S, Mehra R, Chinnaiyan AM: Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature. 2007, 448: 595-599. 10.1038/nature06024.

4. Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, White TA, Stojanov P, Van Allen E, Stransky N, Nickerson E, Chae SS, Boysen G, Auclair D, Onofrio RC, Park K, Kitabayashi N, MacDonald TY, Sheikh K, Vuong T, Guiducci C, Cibulskis K, Sivachenko A, Carter SL, Saksena G, Voet D, Hussain WM, Ramos AH, Winckler W, Redman MC, et al: Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet. 2012, 44: 685-689. 10.1038/ng.2279.

5. Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, Siddiqui J, Sam L, Anstett M, Mehra R, Prensner JR, Palanisamy N, Ryslik GA, Vandin F, Raphael BJ, Kunju LP, Rhodes DR, Pienta KJ, Chinnaiyan AM, Tomlins SA: The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012, 487: 239-243. 10.1038/nature11125.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells;The Prostate;2024-08-18

2. Bulk and single-cell transcriptional profiles reveal roles of fibroblasts and immunocytes in pan-cancer progression;2024-04-30

3. Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study;Cancer Epidemiology, Biomarkers & Prevention;2023-08-09

4. Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer;Cancer Gene Therapy;2023-07-14

5. Current status and clinical application of patient-derived tumor organoid model in kidney and prostate cancers;BMB Reports;2022-12-02